Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
Список исп. литературыСкрыть список 1. Чучалин А.Г. Абросимов В.Н. Кашель. М.: ГЭОТАР-Медиа, 2016. ISBN 978-5-9704-3728-5. URL: https://www.rosmedlib.ru/book/ISBN9785970437285.html [Chuchalin A.G. Abrosimov V.N. Kashel'. Moscow: GEOTAR-Media, 2016. ISBN 978-5-9704-3728-5. URL: https://www.rosmedlib.ru/ book/ISBN9785970437285.html (in Russian).] 2. Braman SS. Postinfectious cough: ACCP evidencebased clinical practice guidelines. Chest 2006; 129 (Suppl. ): 138S–147S. 3. Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax 2006; 61 (Suppl. 1): 1–24. 4. Madison JM, Irwin RS. Cough. Comprehensive respiratory medicine. Ed. R. Albert, S. Spiro, J. Jett. 2nd ed. London: Harcourt Publishers Limitel, 2001. P. 15.1–15.6. 5. Morice AH, Fontana GA, Belvisi MG et al. ERS guidelines on the assessment of cough. Eur Respir J 2007; 29: 1256–76. 6. Руководства для врачей общей практики (семейных врачей). Кашель. М., 2015. [Rukovodstva dlia vrachei obshchei praktiki (semeinykh vrachei). Kashel'. Moscow, 2015 (in Russian).] 7. Wiersinga WJ, Rhodes A, Cheng AC et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020; 324 (8): 782–93. DOI: 10.1001/jama.2020.12839. PMID: 32648899. 8. Garg D, Srivastava AK, Dhamija RK. Beyond Fever, Cough and Dyspnea: The Neurology of COVID-19. J Assoc Physicians India 2020; 68 (9): 62–6. PMID: 32798347. 9. Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci 2020; 41 (10): 2657–69. DOI: 10.1007/s10072-020-04575-3. PMID: 32725449; PMCID: PMC7385206. 10. Hoffmann M, Kleine-Weber H, Schroeder S et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181 (2): 271–280. DOI: 10.1016/j.cell.2020.02.052 11. Mancia G, Rea F, Ludergnani M et al. Renin-angiotensin-aldosterone system blockers and the risk of COVID-19. N Engl J Med 2020; 382 (25): 2431–40. DOI: 10.1056/NEJMoa2006923 12. Alam SB, Willows S, Kulka M. Sandhu JK. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur J Neurol 2020; 15: 10.1111/ene.14442. DOI: 10.1111/ene.14442. 13. Sungnak W, Huang N, Becavin C et al. SARS‐CoV‐2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 2020; 26: 681–7. 14. Lechien JR, Chiesa-Estomba CM, De Siati DR et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277 (8): 2251–61. 15. Pascarella G, Strumia A, Piliego C et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med 2020; 288 (2): 192–206. DOI: 10.1111/joim.13091. PMID: 32348588; PMCID: PMC7267177. 16. Puzyrenko A, Felix JC, Ledeboer NA et al. Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis. Pathology 2021: S0031-3025 (21): 00514-6. DOI: 10.1016/j.pathol.2021.09.005. PMID: 34836647; PMCID: PMC8572726. 17. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020; 8 (8): 807–15. DOI: 10.1016/S2213-2600(20)30225-3. PMID: 32422178; PMCID: PMC7228727. 18. Puzyrenko A, Felix JC, Sun Y, Rui H, Sheinin Y. Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: case report and review of the literature. Pathol Res Pract 2021; 220: 153380. 19. Vitiello A, Pelliccia C, Ferrara F. COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy. SN Compr Clin Med 2020. Aug 27: 1–4. DOI: 10.1007/s42399-020-00487-7. PMID: 32875276; PMCID: PMC7452615. 20. Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med 2017; 11 (5): 343–59. DOI: 10.1080/17476348.2017.1312346. PMID: 28345383. 21. Wuyts WA, Wijsenbeek M, Bondue B et al. Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease. Respiration 2020; 99 (1): 73–82. DOI: 10.1159/000504763. PMID: 31830755; PMCID: PMC6979429. 22. Рачина С.А., Козлов Р.С., Таточенко В.К. и др. Практика лечения острых респираторных инфекций у детей в амбулаторнополиклинических учреждениях РФ: результаты многоцентрового фармакоэпидемиологического исследования. Клиническая фармакология и терапия. 2016; 25 (2): 20–7. [Rachina S.A., Kozlov R.S., Tatochenko V.K. et al. Praktika lecheniia ostrykh respiratornykh infektsii u detei v ambulatornopoliklinicheskikh uchrezhdeniiakh RF: rezul'taty mnogotsentrovogo farmakoepidemiologicheskogo issledovaniia. Klinicheskaia farmakologiia i terapiia. 2016; 25 (2): 20–7 (in Russian).] 23. Grigoryan L, Zoorob R, Shah J et al. Antibiotics prescribing for uncomplicated acutebronchitis is highest in younger adults. Antibiotics (Basel, Switzerland) 2017; 6 (4). PII: E22. DOI: 10.3390/antibiotics6040022 24. Клячкина И.Л., Синопальников А.И. Амброксол в программе лечения хронических бронхолегочных заболеваний. Практическая пульмонология. 2018; 2: 83–92. [Kliachkina I.L., Sinopal'nikov A.I. Ambroksol v programme lecheniia khronicheskikh bronkholegochnykh zabolevanii. Prakticheskaia pul'monologiia. 2018; 2: 83–92 (in Russian).] 25. Seifart C, Clostermann U, Seifart U et al. Cell-specific modulation of surfactant proteins by ambroxol treatment. Toxicology and Applied Pharmacology 2005; 203 (1): 27–35. 26. Raghu G, Collard HR, Egan JJ et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 (6): 788-824.